Back
Daiichi Sankyo Vs. Nxera Pharma Industry Stock Comparison
Sell
47
DSNKY
Daiichi Sankyo
Last Price:
34.49
Seasonality Move:
2.16%
Sell
38
SOLTF
Nxera Pharma
Last Price:
9.82
Seasonality Move:
21.23%
Sell
47
Daiichi Sankyo (DSNKY)
is a Sell
Is Daiichi Sankyo a Buy, Sell or Hold?
- The current Daiichi Sankyo [DSNKY] share price is $34.49. The Score for DSNKY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- DSNKY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $9.82. The Score for SOLTF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DSNKY Stock Price Chart
What is Daiichi Sankyo's stock price today?
-
The Daiichi Sankyo share price today is $34.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSNKY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $9.82
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
DSNKY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.97 | Buy |
| Relative Strength Index (14 RSI): | 61.63 | Buy |
| Chaikin Money Flow: | 30830 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.58 - 34.08) | Buy |
| Bollinger Bands (100): | (28.86 - 33.2) | Buy |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 51.77 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.39 - 10.19) | Buy |
| Bollinger Bands (100): | (9.24 - 10.8) | Sell |
DSNKY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.68 | Sell |
| 20-day SMA: | 32.26 | Buy |
| 50-day SMA: | 32.01 | Buy |
| 200-day SMA: | 29.47 | Buy |
| 8-day EMA: | 34.1 | Buy |
| 20-day EMA: | 33.03 | Buy |
| 50-day EMA: | 32.07 | Buy |
| 200-day EMA: | 30.58 | Buy |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.55 | Buy |
| 20-day SMA: | 9.63 | Buy |
| 50-day SMA: | 10.19 | Sell |
| 200-day SMA: | 10.22 | Sell |
| 8-day EMA: | 9.63 | Buy |
| 20-day EMA: | 9.7 | Buy |
| 50-day EMA: | 9.9 | Sell |
| 200-day EMA: | 10.81 | Sell |
Daiichi Sankyo Earnings Growth & DSNKY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Daiichi Sankyo Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||